Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
TCOYD Making the Connection Between Patients and Providers: A Modern Approach to the Treatment of Type 1 and Type 2 Diabetes Virtual Edition - October 2020
This program will focus on four distinct areas of the most cutting-edge diabetes management strategies: Patient-provider relationships with a focus on communication methods to improve adherence and persistence; Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health; Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact; Time in range and the unmet needs of type 1 diabetes
Activity Details
Activity Name: TCOYD Making the Connection Between Patients and Providers: A Modern Approach to the Treatment of Type 1 and Type 2 Diabetes Virtual Edition - October 2020
Description: This program will focus on four distinct areas of the most cutting-edge diabetes management strategies: Patient-provider relationships with a focus on communication methods to improve adherence and persistence; Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health; Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact; Time in range and the unmet needs of type 1 diabetes
Course Objectives: Upon completion of this course, participants should be able to:

  • Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable).
  • Develop individualized treatment strategies based on the living standards of care and patient characteristics.
  • Discuss the recently published cardiovascular-renal outcome trials on oral and injectable type 2 medications.
  • Summarize the most up-to-date clinical information on GLP-1 RA and SGLT-2 inhibitors.
  • Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).
  • Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies.
  • and the basal-bolus approach.
  • Design a treatment plan for multiple daily injection regimens and insulin pump therapy.
  • Explain how to interpret continuous glucose monitoring (CGM) data.
  • Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.
  • Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
  • Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.
Location Information
Meeting Location: Virtual - Pacific Time
Location Country: US
Activity Information
Start Date: 10/3/2020
End Date: 10/3/2020
Fees: $25
Meeting URL: https://tcoyd.org/mtc-virtual-oct-2020/
Credit Information
Credit Amount: 6.0
Credit Unit: Credits
Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format: Live Activity
Accreditor/Sponsor
Sponsor Name: UC San Diego School of Medicine
Sponsor Address: 9500 Gilman Drive, MC 0947
Sponsor City: La Jolla
Sponsor State: CA
Sponsor Postal Code: 92093
Sponsor Country: US
Sponsor Phone: +1-858-534-3940
Sponsor Email: ocme@health.ucsd.edu
Contact Information
Contact Name: Taking Control of Your Diabetes
Contact Phone: 800-998-2693
Contact Email: robyn@tcoyd.org

Type:     Live Activity
0 Registered Users